Author: Zacks Small Cap Research

1239710 / 966 POSTS
By David Bautz, PhDNASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Cycle 3 Data Shows Continued Efficacy for SGX301 in Phase 3 CTCL Trial On October 22, 2020, Soligenix, Inc. (NASDAQ:SNGX) announced data from Cycle 3 of the Phase 3 FLA ...
By David Bautz, PhDNASDAQ:BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Manufacturing Agreement with Catalent On October 22, 2020, BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI) announced an agreement with Catalent, Inc. (CTLT) for the ma ...
By Steven Ralston, CFANYSE:XIN READ THE FULL XIN RESEARCH REPORT Xinyuan Real Estate (NYSE:XIN) develops and sells real estate properties, primarily large-scale, high quality, multi-family residential projects in strategically selected high growth ci ...
By David Bautz, PhDNASDAQ:MDNA READ THE FULL MDNA RESEARCH REPORT Business Update Phase 3 Plan for MDNA55 Program On October 15, 2020, Medicenna Therapeutics Corp. (NASDAQ:MDNA) provided an update for the MDNA55 program following an ‘End-of-Phase 2’ ...
By John Vandermosten, CFANASDAQ:LTRN READ THE FULL LTRN RESEARCH REPORT Initiating Coverage We are initiating coverage of Lantern Pharma Inc., (NASDAQ:LTRN) with a current valuation of $28 per share. Lantern is a new type of drug development company ...
By David Bautz, PhDNASDAQ:BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Topline Data from Phase 3 ALS Trial Before End of November 2020 BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI) is currently conducting a Phase 3 clinical trial of Nur ...
By Beth Senko, CFAOTC:UCASU READ THE FULL UCASU RESEARCH REPORT The pandemic continues to throw uncertainty into the economy and markets, making it difficult, if not impossible, for many to look past 2020, or even next week. Recent studies suggest th ...
By John Vandermosten, CFANASDAQ:NOVN Novan, Inc. (NASDAQ:NOVN) announced today that in vitro investigation of NITRICIL’s (berdazimer sodium) antiviral effect against SARS-CoV-2 infected 3D tissue model produced favorable results, demonstrating the po ...
By M. MarinNASDAQ:AEMD READ THE FULL AEMD RESEARCH REPORT Aethlon Medical Inc. (NASDAQ:AEMD) is a medical technology company engaged in developing products to diagnose and treat diseases in oncology and viral diseases that are life and organ threaten ...
NASDAQ:ANPC Biophysical Properties of Blood and Cancer Overview AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) adopts a novel approach to screening and detecting cancer that we see as establishing a new paradigm in routine checkup screening, as we ...
1239710 / 966 POSTS